1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow andexanet alfa: new trials by email Literature Review of andexanet alfa trials Research Report on andexanet alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor andexanet alfa, Usual Care - Acute Intracranial Hemorrhage | Phase 4 | Completed | Alexion Pharmaceuticals, Inc. | 530 | 2019-06-06 | 2024-07-03 |
Thrombosis (1)
Alexion Pharmaceuticals, Inc. (1)
Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Italy (1) · Latvia (1) · Lithuania (1) · Netherlands (1)
PMID 38264861, PMID 38749032, PMID 39167819, PMID 40289797, PMID 42093656
2018 (1)